Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study.
Conclusions: Hypertension is a common comorbidity in patients with COVID-19 and associated with adverse outcomes. Key messagesHypertension was identified as the comorbidity associated with the prognosis of COVID-19in this retrospective cohort.Patients with hypertension could experience an increased risk of thecomposite endpoint.Anti-hypertensive therapy did not affect patient outcomes.
PMID: 32716217 [PubMed - as supplied by publisher]
Source: Annals of Medicine - Category: Internal Medicine Tags: Ann Med Source Type: research
More News: Chronic Obstructive Pulmonary | Coronavirus | COVID-19 | Diabetes | Diabetes Mellitus | Endocrinology | Hypertension | Intensive Care | Internal Medicine | Study